UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 330

Sortiert nach

Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children

JAMA pediatrics, 2019-03, Vol.173 (3), p.280

2019

Volltextzugriff (PDF)

Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception

BMC public health, 2011-12, Vol.11 (1), p.943-943, Article 943

2011

Volltextzugriff (PDF)

Does rotavirus turn on type 1 diabetes?

PLoS pathogens, 2019-10, Vol.15 (10), p.e1007965-e1007965

2019

Volltextzugriff (PDF)

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

The Lancet infectious diseases, 2019-01, Vol.19 (1), p.e31-e38

2019

Volltextzugriff (PDF)

Maternal Vaccination and Infant Influenza and Pertussis

Pediatrics (Evanston), 2021-09, Vol.148 (3), p.1

2021

Volltextzugriff (PDF)

Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017

Medical journal of Australia, 2019-06, Vol.210 (10), p.454-462

2019

Volltextzugriff (PDF)

A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses

Frontiers in immunology, 2022-07, Vol.13, p.914167-914167

2022

Volltextzugriff (PDF)

The Australian model of immunization advice and vaccine funding

Vaccine, 2010-04, Vol.28 (S1), p.A76-A83

Nolan, Terry M

2010

Volltextzugriff (PDF)

Immunization During Pregnancy: Impact on the Infant

Paediatric drugs, 2017-08, Vol.19 (4), p.313-324

2017

Volltextzugriff (PDF)

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Pediatrics (Evanston), 2006-11, Vol.118 (5), p.2135

2006

Volltextzugriff (PDF)

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

Human vaccines & immunotherapeutics, 2019-12, Vol.15 (12), p.2940-2951

2019

Volltextzugriff (PDF)

The Platform Technology Approach to mRNA Product Development and Regulation

Vaccines (Basel), 2024-05, Vol.12 (5), p.528

2024

Volltextzugriff (PDF)

4CMenB journey to the 10-year anniversary and beyond

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2357924

2024

Volltextzugriff (PDF)

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2324547-2324547

2024

Volltextzugriff (PDF)

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial

Vaccine, 2015-05, Vol.33 (21), p.2485-2492

2015

Volltextzugriff (PDF)

National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015

Australian and New Zealand journal of public health, 2021-10, Vol.45 (5), p.455-461

2021

Volltextzugriff (PDF)

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine

Human vaccines & immunotherapeutics, 2021-01, Vol.17 (1), p.176-190

2021

Volltextzugriff (PDF)

Public health management of pertussis in adults: Practical challenges and future strategies

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2377904

2024

Volltextzugriff (PDF)

Normative data for the Strengths and Difficulties Questionnaire for young children in Australia

Journal of paediatrics and child health, 2015-10, Vol.51 (10), p.970-975

2015

Volltextzugriff (PDF)

Improving influenza vaccination coverage in pregnancy in Melbourne 2010-2011

Australian & New Zealand journal of obstetrics & gynaecology, 2012-08, Vol.52 (4), p.334-341

2012

Volltextzugriff (PDF)

Excess mortality among people with communicable diseases over a 30-year period, Victoria, Australia: a whole of population cohort study

The Lancet regional health. Western Pacific, 2023-09, Vol.38, p.100815-100815, Article 100815

2023

Volltextzugriff (PDF)

Usefulness of published PCR primers in detecting human rhinovirus infection

Emerging infectious diseases, 2011-02, Vol.17 (2), p.296-298

2011

Volltextzugriff (PDF)

Group Testing for SARS-CoV-2: Forward to the Past?

PharmacoEconomics - open, 2020-06, Vol.4 (2), p.207-210

2020

Volltextzugriff (PDF)

Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts

Vaccines (Basel), 2024-07, Vol.12 (7), p.773

2024

Volltextzugriff (PDF)

Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus-Like-Particle Vaccine

The Journal of infectious diseases, 2007-10, Vol.196 (8), p.1153-1162

2007

Volltextzugriff (PDF)

1 – 25 von 330

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(288)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(329)
Japanisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Association of Rotavirus Vaccination With the Incidence of Type 1 Diabetes in Children

Making sense of perceptions of risk of diseases and vaccinations: a qualitative study combining models of health beliefs, decision-making and risk perception

Does rotavirus turn on type 1 diabetes?

Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine

Maternal Vaccination and Infant Influenza and Pertussis

Influenza and pertussis vaccination of women during pregnancy in Victoria, 2015–2017

A Complementary Union of SARS-CoV2 Natural and Vaccine Induced Immune Responses

The Australian model of immunization advice and vaccine funding

Immunization During Pregnancy: Impact on the Infant

Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women

Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults

The Platform Technology Approach to mRNA Product Development and Regulation

4CMenB journey to the 10-year anniversary and beyond

Understanding the impact of adult pertussis and current approaches to vaccination: A narrative review and expert panel recommendations

Safety, immunogenicity, and lot-to-lot consistency of a quadrivalent inactivated influenza vaccine in children, adolescents, and adults: A randomized, controlled, phase III trial

National predictors of influenza vaccine uptake in pregnancy: the FluMum prospective cohort study, Australia, 2012–2015

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine

Public health management of pertussis in adults: Practical challenges and future strategies

Normative data for the Strengths and Difficulties Questionnaire for young children in Australia

Improving influenza vaccination coverage in pregnancy in Melbourne 2010-2011

Excess mortality among people with communicable diseases over a 30-year period, Victoria, Australia: a whole of population cohort study

Usefulness of published PCR primers in detecting human rhinovirus infection

Group Testing for SARS-CoV-2: Forward to the Past?

Capturing the Value of Vaccination within Health Technology Assessment and Health Economics—Practical Considerations for Expanding Valuation by Including Key Concepts

Impact of Baseline Covariates on the Immunogenicity of a Quadrivalent (Types 6, 11, 16, and 18) Human Papillomavirus Virus-Like-Particle Vaccine

Suchergebnisse filtern